IMEC and Silterra Further Memory Joint Development Project

Silterra Malaysia, a leading foundry in Malaysia and IMEC, Europe’s leading independent nanoelectronics and nanotechnology research center based in Belgium, today announced that they have signed an agreement for a joint development project (JDP) to create a foundry-compatible 90-nm CMOS process technology with intention to further scale to 65-nm. A 110-nm derivative will also be developed in parallel. This collaborative project is an extension of the JDP conducted earlier for the 0.13-micron (130-nm) technology and which is already in production at Silterra.

The technology will be ready for production in the second half of 2008 or earlier and will, among other things, utilize low-K inter-metal dielectric and the 193-nm patterning process. The smaller geometries will allow for smaller die sizes and faster transistors, bringing a better price-performance profile to Silterra’s customers. A team of Silterra and IMEC engineers will fine-tune the base-IMEC process at IMEC’s research facility in Leuven to meet the specifications defined by Silterra. The process will have physical design rules and electrical characteristics that match mainstream technologies, enabling customers to seamlessly support their multi-foundry sourcing strategy.

“Silterra is committed to the pure foundry business and more advanced process technology development is essential to support the success of our customers. Many of our major customers adopted the multi-foundry strategy and we will continue to grow with them. This project paves the way towards future technology nodes and a migration path to 300mm,” said Kah-Yee Eg, CEO of Silterra. “As proven in our earlier engagement with IMEC, this JDP will enable Silterra to bring a new process into production quickly.”

“We are very pleased that we will continue the successful collaboration with Silterra to develop a foundry process that will benefit such a wide customer base,” stated Prof. Gilbert Declerck, president and CEO of IMEC. “Our 90-nm platform technology is a great starting point to build on because it is proven and will help shorten development cycle times significantly.”

The new process, like Silterra’s own foundry compatible 0.13- and 0.18-micron logic technologies, is targeted for a wide range of products for consumer, communications and computational applications. In addition, the technology is also optimized for CPU, DSP and graphics applications. This jointly developed foundry process opens the door for Silterra to collaborate with other foundry players in rapidly bringing advanced node densities to production.

“We see significant business growth in the next 2-3 years and will continue to actively invest in process technology,” said Eg. “We had built up strong in-house capabilities in developing process technologies for specific applications such as RF, High Voltage and Low Power in 0.18-micron for the past few years and we are currently developing these application specific process technologies on 0.13-micron. We will continue to move these technologies down to 90-nm and 65-nm with our customers. Our aim is to offer the best total solution to our customers – and the availability of technologies for the right process node is critical to that goal.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    IMEC. (2019, March 19). IMEC and Silterra Further Memory Joint Development Project. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=4262.

  • MLA

    IMEC. "IMEC and Silterra Further Memory Joint Development Project". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=4262>.

  • Chicago

    IMEC. "IMEC and Silterra Further Memory Joint Development Project". AZoNano. https://www.azonano.com/news.aspx?newsID=4262. (accessed November 21, 2024).

  • Harvard

    IMEC. 2019. IMEC and Silterra Further Memory Joint Development Project. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=4262.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.